Osteoporosis: Challenges and New Opportunities for Therapy
Document Type
Article
Publication Date
7-1-2002
Abstract
Osteoporosis is a chronic disease that affects a large number of both men and women and is characterized by a decrease in bone mass, as well as weakened bones. It causes a significant amount of morbidity and mortality in patients and is often only diagnosed after a fracture occurs. This review will highlight recent advances in the development of novel anabolic approaches for treatment of osteoporosis, such as parathyroid hormone (PTH), calcium sensing receptor modulators, statins and prostanoid receptor agonists. Selected antiresorptive targets (cathepsin K inhibitors and vitronectin receptor antagonists) will also be surveyed.
Montclair State University Digital Commons Citation
Rotella, David, "Osteoporosis: Challenges and New Opportunities for Therapy" (2002). Department of Chemistry and Biochemistry Faculty Scholarship and Creative Works. 215.
https://digitalcommons.montclair.edu/chem-biochem-facpubs/215